Huntington's disease: progress and potential in the field

Area of Science:

• Neuroscience
• Genetics
• Pharmacology

Background:

• Huntington's disease (HD) is a fatal neurodegenerative disorder with no existing cure.
• HD pathogenesis stems from a CAG repeat expansion in the huntingtin gene, leading to toxic mutant protein expression.
• Key mechanisms include protein aggregation, mitochondrial dysfunction, oxidative stress, and excitotoxicity.

Purpose of the Study:

• To review current understanding of Huntington's disease pathogenic mechanisms.
• To highlight therapeutic strategies targeting specific disease pathways.
• To discuss compounds showing preclinical and clinical promise for HD treatment.

Main Methods:

• Literature review of studies on Huntington's disease mechanisms.
• Analysis of preclinical data from transgenic HD mouse models.
• Evaluation of human clinical trial outcomes for potential HD therapies.

Main Results:

• Significant progress in elucidating HD's complex molecular pathology.
• Identification of multiple therapeutic targets based on disease mechanisms.
• Encouraging preclinical efficacy and some clinical success reported for various compounds.

Conclusions:

• Understanding HD's pathogenic pathways is crucial for developing effective treatments.
• Targeted therapeutic strategies show promise in preclinical and early clinical studies.
• Further research and clinical trials are essential to identify successful HD therapies.